Suppr超能文献

δ-氨基-γ-酮戊酸脱水酶(ALAD)缺乏型血卟啉病中ALAD缺陷的高度异质性。

Highly heterogeneous nature of delta-aminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria.

作者信息

Maruno M, Furuyama K, Akagi R, Horie Y, Meguro K, Garbaczewski L, Chiorazzi N, Doss M O, Hassoun A, Mercelis R, Verstraeten L, Harper P, Floderus Y, Thunell S, Sassa S

机构信息

Rockefeller University, New York, NY; Okayama Prefectural University, Okayama, Japan.

出版信息

Blood. 2001 May 15;97(10):2972-8. doi: 10.1182/blood.v97.10.2972.

Abstract

The properties of 9 delta-aminolevulinate dehydratase (ALAD) mutants from patients with ALAD porphyria (ADP) were examined by bacterial expression of their complementary DNAs and by enzymologic and immunologic assays. ALADs were expressed as glutathione-S-transferase (GST) fusion proteins in Escherichia coli and purified by glutathione-affinity column chromatography. The GST-ALAD fusion proteins were recognized by anti-ALAD antibodies and were enzymatically active as ALAD. The enzymatic activities of 3 ALAD mutants, K59N, A274T, and V153M, were 69.9%, 19.3%, and 41.0% of that of the wild-type ALAD, respectively, whereas 6 mutants, G133R, K59N/G133R, F12L, R240W, V275M, and delTC, showed little activity (< 8%). These variations generally reflect the phenotype of ALAD in vivo in patients with ADP and indicate that GST-ALAD fusion protein is indeed useful for predicting of the phenotype of ALAD mutants. The location of F12L mutation in the enzyme's molecular structure indicates that its disturbance of the quaternary contact of the ALAD dimer appears to have a significant influence on the enzymatic activity. Mouse monoclonal antibodies to human ALAD were developed that specifically recognized a carboxy terminal portion of ALAD, or other regions in the enzyme. This study represents the first complete analysis of 9 mutants of ALAD identified in ADP and indicates the highly heterogeneous nature of mutations in this disorder.

摘要

通过对来自δ-氨基-γ-酮戊酸脱水酶(ALAD)卟啉症(ADP)患者的9种ALAD突变体的互补DNA进行细菌表达,并通过酶学和免疫学检测来研究其特性。ALADs在大肠杆菌中作为谷胱甘肽-S-转移酶(GST)融合蛋白表达,并通过谷胱甘肽亲和柱色谱法纯化。GST-ALAD融合蛋白可被抗ALAD抗体识别,并具有ALAD的酶活性。3种ALAD突变体K59N、A274T和V153M的酶活性分别为野生型ALAD的69.9%、19.3%和41.0%,而6种突变体G133R、K59N/G133R、F12L、R240W、V275M和delTC的活性很低(<8%)。这些变异通常反映了ADP患者体内ALAD的表型,并表明GST-ALAD融合蛋白确实可用于预测ALAD突变体的表型。F12L突变在酶分子结构中的位置表明,其对ALAD二聚体四级接触的干扰似乎对酶活性有重大影响。已开发出针对人ALAD的小鼠单克隆抗体,该抗体可特异性识别ALAD的羧基末端部分或酶中的其他区域。本研究首次对在ADP中鉴定出的9种ALAD突变体进行了完整分析,并表明该疾病中突变具有高度异质性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验